Real-time enrollment status for this schizophrenia clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 7:34 PM UTC
| NCT Number | NCT07467993 |
| Recruiting Status | Recruiting |
| Condition | Schizophrenia |
| Phase | PHASE2 |
| Target Enrollment | 142 participants |
| Active Locations | 7 sites in the US |
| Sponsor | Novartis Pharmaceuticals |
| Last Updated on CT.gov | July 29, 2026 (Jul 29, 2026) |
As of August 28, 2026: Clinical trial NCT07467993 is currently recruiting participants. This phase2 study for schizophrenia is actively seeking new participants at 7 locations across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07467993 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07467993 was last updated Jul 29, 2026 (July 29, 2026). HelloStudys verifies this status automatically.